Remedent Stock Today

REMI Stock  USD 0.05  0.00  0.00%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Remedent is trading at 0.05 as of the 1st of March 2025. This is a No Change since the beginning of the trading day. The stock's open price was 0.05. Remedent has about a 43 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 12th of March 2023 and ending today, the 1st of March 2025. Click here to learn more.
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. The company was founded in 1986 and is headquartered in Ghent, Belgium. Remedent operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 20 M outstanding shares. More on Remedent

Moving against Remedent Pink Sheet

  0.69VZ Verizon Communications Sell-off TrendPairCorr
  0.64PG Procter GamblePairCorr
  0.63SWZNF Schweizerische NationalbankPairCorr
  0.63JNJ Johnson JohnsonPairCorr
  0.61BRK-A Berkshire HathawayPairCorr
  0.61BRK-B Berkshire HathawayPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Remedent Pink Sheet Highlights

ChairmanGuy Vreese
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors)
Remedent [REMI] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Remedent's market, we take the total number of its shares issued and multiply it by Remedent's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Remedent conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 20 M outstanding shares. Remedent currently holds about 83.3 K in cash with 250.56 K of positive cash flow from operations.
Check Remedent Probability Of Bankruptcy
Ownership Allocation
Remedent owns a total of 20 Million outstanding shares. Remedent has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Remedent Ownership Details

Remedent Risk Profiles

Remedent Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Remedent without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Other Information on Investing in Remedent Pink Sheet

Remedent financial ratios help investors to determine whether Remedent Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Remedent with respect to the benefits of owning Remedent security.